S Vincent Rajkumar Selected Research

Immunoglobulin lambda-Chains

1/2008	Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma.
8/2005	Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

S Vincent Rajkumar Research Topics

Disease

197	Multiple Myeloma 10/2022 - 02/2002
62	Immunoglobulin Light-chain Amyloidosis 01/2022 - 02/2002
31	Neoplasms (Cancer) 01/2022 - 02/2002
30	Amyloidosis 01/2022 - 06/2002
28	Monoclonal Gammopathy of Undetermined Significance 01/2022 - 09/2002
20	Paraproteinemias (Monoclonal Gammopathy) 01/2022 - 01/2002
19	Waldenstrom Macroglobulinemia (Macroglobulinemia) 08/2018 - 01/2002
16	Smoldering Multiple Myeloma 10/2020 - 02/2002
15	Renal Insufficiency (Renal Failure) 01/2022 - 01/2005
14	Anemia 01/2022 - 01/2003
14	Disease Progression 01/2021 - 07/2004
10	Hypercalcemia (Milk Alkali Syndrome) 01/2022 - 01/2003
10	Plasmacytoma 01/2022 - 02/2002
8	Proteinuria 01/2022 - 09/2005
8	Lymphoma (Lymphomas) 01/2018 - 02/2002
6	POEMS Syndrome (Syndrome, POEMS) 01/2022 - 04/2003
6	Hematologic Neoplasms (Hematological Malignancy) 01/2021 - 02/2002
5	Infections 02/2022 - 11/2002
5	Bone Diseases (Bone Disease) 01/2019 - 12/2002
5	Venous Thrombosis (Deep-Vein Thrombosis) 10/2008 - 09/2003
4	Thrombocytopenia (Thrombopenia) 08/2020 - 01/2007
4	Peripheral Nervous System Diseases (PNS Diseases) 08/2020 - 09/2003
4	Venous Thromboembolism 01/2020 - 11/2007
4	Chromosome Aberrations (Chromosome Abnormalities) 10/2018 - 08/2002
4	Glomerulonephritis 03/2016 - 11/2013
4	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 05/2015 - 02/2002
4	Exanthema (Rash) 01/2007 - 09/2003
3	Thrombosis (Thrombus) 01/2022 - 04/2008
3	Trisomy (Trisomies) 12/2020 - 01/2019
3	Celiac Disease (Celiac Sprue) 01/2020 - 03/2015
3	Pain (Aches) 01/2019 - 08/2006
3	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2018 - 09/2006
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2018 - 02/2010
3	Necrosis 12/2012 - 10/2003
3	Pulmonary Embolism 12/2008 - 11/2002
3	Neutropenia 10/2008 - 01/2007
3	Fatigue 01/2007 - 09/2003
2	Vitamin D Deficiency 01/2022 - 07/2009
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2022 - 07/2004

Drug/Important Bio-Agent (IBA)

52	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2002
51	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022 - 11/2002
46	Lenalidomide (CC 5013)FDA Link 01/2021 - 04/2005
31	Bortezomib (Velcade)FDA Link 01/2022 - 06/2003
28	Thalidomide (Thalomid)FDA Link 09/2015 - 11/2002
25	Immunoglobulins (Immunoglobulin)IBA 02/2022 - 08/2002
23	Immunoglobulin M (IgM)IBA 01/2021 - 01/2002
16	Biomarkers (Surrogate Marker)IBA 01/2021 - 05/2004
12	Pharmaceutical PreparationsIBA 01/2022 - 12/2002
12	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 01/2021 - 06/2002
11	Amyloid (Amyloid Fibrils)IBA 01/2020 - 04/2006
10	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 05/2009
10	ixazomibIBA 01/2022 - 11/2016
10	Proteasome InhibitorsIBA 01/2022 - 03/2006
10	Immunoglobulin A (IgA)IBA 01/2021 - 08/2003
8	Immunomodulating AgentsIBA 01/2022 - 10/2009
8	pomalidomideIBA 03/2021 - 10/2009
8	Immunoglobulin G (IgG)IBA 01/2018 - 08/2003
7	Melphalan (Alkeran)FDA LinkGeneric 01/2019 - 05/2009
6	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021 - 03/2007
6	Rituximab (Mabthera)FDA Link 08/2018 - 09/2006
6	Biological ProductsIBA 06/2012 - 02/2002
6	CytokinesIBA 01/2012 - 09/2003
5	pro-brain natriuretic peptide (1-76)IBA 01/2019 - 10/2010
5	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2019 - 09/2004
5	AlbuminsIBA 01/2017 - 06/2007
5	CreatinineIBA 01/2016 - 01/2003
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2012 - 09/2003
4	PanobinostatIBA 01/2021 - 10/2014
4	AntibodiesIBA 01/2021 - 09/2006
4	Dihydrotachysterol (AT 10)IBA 10/2014 - 11/2003
4	Alkylating AgentsIBA 05/2012 - 07/2004
4	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2010 - 03/2005
4	Serum AlbuminIBA 07/2009 - 11/2003
3	3,4-methylenedioxyethamphetamine (MDEA)IBA 01/2022 - 01/2016
3	Monoclonal AntibodiesIBA 01/2022 - 09/2006
3	venetoclaxIBA 01/2021 - 10/2019
3	daratumumabIBA 01/2021 - 04/2016
3	Congo RedIBA 01/2019 - 10/2016
3	Troponin T (Troponin T1)IBA 10/2016 - 03/2012
3	TroponinIBA 06/2015 - 09/2004
3	Blood Proteins (Serum Proteins)IBA 01/2012 - 04/2010
3	Angiogenesis InhibitorsIBA 11/2009 - 04/2003
3	C-Reactive ProteinIBA 07/2009 - 05/2004
3	Interleukin-6 (Interleukin 6)IBA 02/2009 - 10/2003
3	Proteasome Endopeptidase Complex (Proteasome)IBA 10/2008 - 01/2005
3	Diphosphonates (Bisphosphonates)IBA 08/2006 - 12/2002
2	25-hydroxyvitamin DIBA 01/2022 - 07/2009
2	Hemoglobins (Hemoglobin)IBA 01/2022 - 01/2020
2	Vitamin D FDA LinkGeneric 01/2022 - 07/2009
2	hydroxide ionIBA 01/2022 - 07/2009

Therapy/Procedure

114	Therapeutics 02/2022 - 02/2002
35	Stem Cell Transplantation 01/2022 - 12/2002
12	Drug Therapy (Chemotherapy) 01/2020 - 12/2002
6	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 02/2012 - 05/2004
5	Transplantation 04/2011 - 06/2002
4	Kidney Transplantation 04/2022 - 01/2012
3	Aftercare (After-Treatment) 01/2021 - 07/2015
3	Hematopoietic Stem Cell Transplantation 01/2019 - 09/2012
3	Autologous Transplantation 12/2013 - 12/2009
2	Drug Tapering 10/2022 - 07/2006